Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2013, Article ID 681205, 5 pages
http://dx.doi.org/10.1155/2013/681205
Research Article

Changes in Serum Levels of Bone Morphogenic Protein 4 and Inflammatory Cytokines after Bariatric Surgery in Severely Obese Korean Patients with Type 2 Diabetes

1Department of Internal Medicine, Yeouido St. Mary’s Hospital, The Catholic University of Korea, 62 Yeouido-dong Youngdeungpo-gu, Seoul 150-713, Republic of Korea
2Department of Internal Medicine, Hando Hospital, Seonbu 1-dong, Danwon-gu, Ansan 425-140, Republic of Korea
3Department of Surgery, The Catholic University of Korea, Seoul, Republic of Korea

Received 31 May 2013; Accepted 20 August 2013

Academic Editor: Ricardo V. García-Mayor

Copyright © 2013 Mee Kyoung Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Massagué and Y. G. Chen, “Controlling TGF-beta signaling,” Genes & Development, vol. 14, no. 6, pp. 627–644, 2000. View at Google Scholar
  2. R. R. Bowers and M. D. Lane, “A role for bone morphogenetic protein-4 in adipocyte development,” Cell Cycle, vol. 6, no. 4, pp. 385–389, 2007. View at Google Scholar · View at Scopus
  3. H. Huang, T. Song, X. Li et al., “BMP signaling pathway is required for commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 31, pp. 12670–12675, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Macotela, B. Emanuelli, M. A. Mori et al., “Intrinsic differences in adipocyte precursor cells from different white fat depots,” Diabetes, vol. 61, no. 7, pp. 1691–1699, 2012. View at Google Scholar
  5. J. W. Son, E. H. Jang, M. K. Kim et al., “Serum BMP-4 levels in relation to arterial stiffness and carotid atherosclerosis in patients with Type 2 diabetes,” Biomarkers in Medicine, vol. 5, no. 6, pp. 827–835, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. J. W. Son, M. K. Kim, Y. M. Park et al., “Association of serum bone morphogenetic protein 4 levels with obesity and metabolic syndrome in non-diabetic individuals,” Endocrine Journal, vol. 58, no. 1, pp. 39–46, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. U. Hanusch-Enserer, G. Zorn, J. Wojta et al., “Non-conventional markers of atherosclerosis before and after gastric banding surgery,” European Heart Journal, vol. 30, no. 12, pp. 1516–1524, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. L. Vetter, S. Cardillo, M. R. Rickels, and N. Iqbal, “Narrative review: effect of bariatric surgery on type 2 diabetes mellitus,” Annals of Internal Medicine, vol. 150, no. 2, pp. 94–103, 2009. View at Google Scholar · View at Scopus
  9. M. K. Kim, H. C. Lee, H. Kwon et al., “Visceral obesity is a negative predictor of remission of diabetes 1 year after bariatric surgery,” Obesity, vol. 19, no. 9, pp. 1835–1839, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Lakdawala and A. Bhasker, “Report: Asian consensus meeting on metabolicsurgery. recommendations for the use of bariatric and gastrointestinal metabolic surgery for treatment of obesity and type II diabetes mellitus in the asian population,” Obesity Surgery, vol. 20, no. 7, pp. 929–936, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. J. B. Dixon, P. Zimmet, K. G. Alberti, and F. Rubino, “Bariatric surgery: an IDF statement for obese Type2 diabetes,” Diabetic Medicine, vol. 28, no. 6, pp. 628–642, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. J. B. Buse, S. Caprio, W. T. Cefalu et al., “How do we define cure of diabetes?” Diabetes Care, vol. 32, no. 11, pp. 2133–2135, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Böttcher, H. Unbehauen, N. Klöting et al., “Adipose tissue expression and genetic variants of the bone morphogenetic protein receptor 1A gene (BMPR1A) are associated with human obesity,” Diabetes, vol. 58, no. 9, pp. 2119–2128, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. K. I. Boström, M. Jumabay, A. Matveyenko, S. B. Nicholas, and Y. Yao, “Activation of vascular bone morphogenetic protein signaling in diabetes mellitus,” Circulation Research, vol. 108, no. 4, pp. 446–457, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. H. Lee, S. J. Han, H. C. Kim et al., “Gastrectomy for early gastric cancer is associated with decreased cardiovascular mortality in association with postsurgical metabolic changes,” Annals of Surgical Oncology, vol. 20, no. 4, pp. 1250–1257, 2013. View at Google Scholar
  16. A. Estellés, J. Dalmau, C. Falcó et al., “Plasma PAI-1 levels in obese children-effect of weight loss and influence of PAI-1 promoter 4G/5G genotype,” Thrombosis and Haemostasis, vol. 86, no. 2, pp. 647–652, 2001. View at Google Scholar · View at Scopus
  17. J. B. Dixon, L. M. Chuang, K. Chong et al., “Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes,” Diabetes Care, vol. 36, no. 1, pp. 20–26, 2013. View at Google Scholar
  18. M. Deitel, “Update: why diabetes does not resolve in some patients after bariatric surgery,” Obesity Surgery, vol. 21, no. 6, pp. 794–796, 2011. View at Publisher · View at Google Scholar · View at Scopus